Fidelity International’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.2M | Sell |
26,672
-273,353
| -91% | -$56.7M | ﹤0.01% | 698 |
|
|
2026
Q1 | $67.3M | Sell |
300,025
-148,107
| -33% | -$36.9M | 0.05% | 298 |
|
|
2025
Q4 | $108M | Sell |
448,132
-18,859
| -4% | -$4.82M | 0.08% | 225 |
|
|
2025
Q3 | $128M | Buy |
466,991
+73,058
| +19% | +$20M | 0.1% | 199 |
|
|
2025
Q2 | $102M | Buy |
393,933
+44,199
| +13% | +$10.5M | 0.09% | 220 |
|
|
2025
Q1 | $78.3M | Sell |
349,734
-47,131
| -12% | -$11M | 0.07% | 254 |
|
|
2024
Q4 | $90.8M | Sell |
396,865
-49,529
| -11% | -$11.9M | 0.08% | 232 |
|
|
2024
Q3 | $109M | Sell |
446,394
-334,322
| -43% | -$74.7M | 0.1% | 215 |
|
|
2024
Q2 | $149M | Sell |
780,716
-69,939
| -8% | -$14.2M | 0.15% | 169 |
|
|
2024
Q1 | $168M | Buy |
850,655
+10,625
| +1% | +$1.95M | 0.17% | 155 |
|
|
2023
Q4 | $145M | Buy |
840,030
+597,165
| +246% | +$91.8M | 0.15% | 171 |
|
|
2023
Q3 | $35.9M | Buy |
242,865
+76,107
| +46% | +$13.8M | 0.04% | 343 |
|
|
2023
Q2 | $36.4M | Hold |
166,758
| – | – | 0.04% | 344 |
|
|
2023
Q1 | $36.5M | Buy |
166,758
+27,651
| +20% | +$6M | 0.04% | 325 |
|
|
2022
Q4 | $29M | Buy |
139,107
+16,733
| +14% | +$3.68M | 0.03% | 364 |
|
|
2022
Q3 | $26.7M | Buy |
122,374
+109,571
| +856% | +$24.9M | 0.03% | 371 |
|
|
2022
Q2 | $2.68M | Buy |
12,803
+465
| +4% | +$99K | ﹤0.01% | 640 |
|
|
2022
Q1 | $2.99M | Buy |
+12,338
| New | +$2.98M | ﹤0.01% | 649 |
|
|
2021
Q3 | – | Sell |
-8,291
| Closed | -$2.04M | – | 883 |
|
|
2021
Q2 | $2.04M | Buy |
8,291
+1,549
| +23% | +$326K | ﹤0.01% | 703 |
|
|
2021
Q1 | $1.31M | Buy |
6,742
+3,248
| +93% | +$651K | ﹤0.01% | 704 |
|
|
2020
Q4 | $742K | Buy |
3,494
+317
| +10% | +$63.2K | ﹤0.01% | 665 |
|
|
2020
Q3 | $545K | Buy |
3,177
+2,534
| +394% | +$468K | ﹤0.01% | 652 |
|
|
2020
Q2 | $123K | Buy |
643
+48
| +8% | +$7.85K | ﹤0.01% | 662 |
|
|
2020
Q1 | $87K | Buy |
595
+249
| +72% | +$39.7K | ﹤0.01% | 656 |
|
|
2019
Q4 | $54K | Buy |
346
+334
| +2,783% | +$48.1K | ﹤0.01% | 703 |
|
|
2019
Q3 | $2K | Hold |
12
| – | – | ﹤0.01% | 785 |
|
|
2019
Q2 | $1K | Buy |
12
+2
| +20% | +$222 | ﹤0.01% | 852 |
|
|
2019
Q1 | $1K | Sell |
10
-4
| -29% | -$413 | ﹤0.01% | 828 |
|
|
2018
Q4 | $2K | Sell |
14
-3
| -18% | -$321 | ﹤0.01% | 779 |
|
|
2018
Q3 | $2K | Buy |
+17
| New | +$1.86K | ﹤0.01% | 778 |
|
Other funds holding RMD
Fidelity International's RMD Position: Q2 2026 in Review
Fidelity International reduced its ResMed (RMD) stake by 91% in Q2 2026, selling an estimated $56.7M and leaving 26,672 shares worth $5.2M. The position accounts for ﹤0.01% of the portfolio, ranked #698.
Fidelity International first reported a position in RMD in Q3 2018 and has held it in 30 quarters since. The position peaked at $168M in Q1 2024. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Fidelity International held 26,672 shares of ResMed worth $5.2M as of Q2 2026.
- Fidelity International sold 273,353 ResMed shares in Q2 2026, an estimated $56.7M.
- ResMed made up ﹤0.01% of Fidelity International's portfolio in Q2 2026, its #698 holding.
- Fidelity International first reported a position in ResMed in Q3 2018 and has held it in 30 quarters since.
- Fidelity International's ResMed position peaked at $168M in Q1 2024.
- 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Fidelity International's 13F filing for Q2 2026, filed 13 Aug 2026.